Prednisone Recruiting Phase 3 Trials for Polymyalgia Rheumatica Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03600818Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica